Acute sterol o-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretion.

The primary risk factor for atherosclerotic cardiovascular disease is LDL cholesterol, which can be reduced by increasing cholesterol excretion from the body. Fecal cholesterol excretion can be driven by a hepatobiliary as well as a non-biliary pathway known as transintestinal cholesterol efflux (TI...

Full description

Bibliographic Details
Main Authors: Stephanie M Marshall, Anthony D Gromovsky, Kathryn L Kelley, Matthew A Davis, Martha D Wilson, Richard G Lee, Rosanne M Crooke, Mark J Graham, Lawrence L Rudel, J Mark Brown, Ryan E Temel
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4047063?pdf=render
_version_ 1818912049497899008
author Stephanie M Marshall
Anthony D Gromovsky
Kathryn L Kelley
Matthew A Davis
Martha D Wilson
Richard G Lee
Rosanne M Crooke
Mark J Graham
Lawrence L Rudel
J Mark Brown
Ryan E Temel
author_facet Stephanie M Marshall
Anthony D Gromovsky
Kathryn L Kelley
Matthew A Davis
Martha D Wilson
Richard G Lee
Rosanne M Crooke
Mark J Graham
Lawrence L Rudel
J Mark Brown
Ryan E Temel
author_sort Stephanie M Marshall
collection DOAJ
description The primary risk factor for atherosclerotic cardiovascular disease is LDL cholesterol, which can be reduced by increasing cholesterol excretion from the body. Fecal cholesterol excretion can be driven by a hepatobiliary as well as a non-biliary pathway known as transintestinal cholesterol efflux (TICE). We previously showed that chronic knockdown of the hepatic cholesterol esterifying enzyme sterol O-acyltransferase 2 (SOAT2) increased fecal cholesterol loss via TICE. To elucidate the initial events that stimulate TICE, C57Bl/6 mice were fed a high cholesterol diet to induce hepatic cholesterol accumulation and were then treated for 1 or 2 weeks with an antisense oligonucleotide targeting SOAT2. Within 2 weeks of hepatic SOAT2 knockdown (SOAT2HKD), the concentration of cholesteryl ester in the liver was reduced by 70% without a reciprocal increase in hepatic free cholesterol. The rapid mobilization of hepatic cholesterol stores resulted in a ∼ 2-fold increase in fecal neutral sterol loss but no change in biliary cholesterol concentration. Acute SOAT2HKD increased plasma cholesterol carried primarily in lipoproteins enriched in apoB and apoE. Collectively, our data suggest that acutely reducing SOAT2 causes hepatic cholesterol to be swiftly mobilized and packaged onto nascent lipoproteins that feed cholesterol into the TICE pathway for fecal excretion.
first_indexed 2024-12-19T23:08:25Z
format Article
id doaj.art-86f8bd2c2f1d4a9396001c438bdfade9
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-19T23:08:25Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-86f8bd2c2f1d4a9396001c438bdfade92022-12-21T20:02:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0196e9895310.1371/journal.pone.0098953Acute sterol o-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretion.Stephanie M MarshallAnthony D GromovskyKathryn L KelleyMatthew A DavisMartha D WilsonRichard G LeeRosanne M CrookeMark J GrahamLawrence L RudelJ Mark BrownRyan E TemelThe primary risk factor for atherosclerotic cardiovascular disease is LDL cholesterol, which can be reduced by increasing cholesterol excretion from the body. Fecal cholesterol excretion can be driven by a hepatobiliary as well as a non-biliary pathway known as transintestinal cholesterol efflux (TICE). We previously showed that chronic knockdown of the hepatic cholesterol esterifying enzyme sterol O-acyltransferase 2 (SOAT2) increased fecal cholesterol loss via TICE. To elucidate the initial events that stimulate TICE, C57Bl/6 mice were fed a high cholesterol diet to induce hepatic cholesterol accumulation and were then treated for 1 or 2 weeks with an antisense oligonucleotide targeting SOAT2. Within 2 weeks of hepatic SOAT2 knockdown (SOAT2HKD), the concentration of cholesteryl ester in the liver was reduced by 70% without a reciprocal increase in hepatic free cholesterol. The rapid mobilization of hepatic cholesterol stores resulted in a ∼ 2-fold increase in fecal neutral sterol loss but no change in biliary cholesterol concentration. Acute SOAT2HKD increased plasma cholesterol carried primarily in lipoproteins enriched in apoB and apoE. Collectively, our data suggest that acutely reducing SOAT2 causes hepatic cholesterol to be swiftly mobilized and packaged onto nascent lipoproteins that feed cholesterol into the TICE pathway for fecal excretion.http://europepmc.org/articles/PMC4047063?pdf=render
spellingShingle Stephanie M Marshall
Anthony D Gromovsky
Kathryn L Kelley
Matthew A Davis
Martha D Wilson
Richard G Lee
Rosanne M Crooke
Mark J Graham
Lawrence L Rudel
J Mark Brown
Ryan E Temel
Acute sterol o-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretion.
PLoS ONE
title Acute sterol o-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretion.
title_full Acute sterol o-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretion.
title_fullStr Acute sterol o-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretion.
title_full_unstemmed Acute sterol o-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretion.
title_short Acute sterol o-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretion.
title_sort acute sterol o acyltransferase 2 soat2 knockdown rapidly mobilizes hepatic cholesterol for fecal excretion
url http://europepmc.org/articles/PMC4047063?pdf=render
work_keys_str_mv AT stephaniemmarshall acutesteroloacyltransferase2soat2knockdownrapidlymobilizeshepaticcholesterolforfecalexcretion
AT anthonydgromovsky acutesteroloacyltransferase2soat2knockdownrapidlymobilizeshepaticcholesterolforfecalexcretion
AT kathrynlkelley acutesteroloacyltransferase2soat2knockdownrapidlymobilizeshepaticcholesterolforfecalexcretion
AT matthewadavis acutesteroloacyltransferase2soat2knockdownrapidlymobilizeshepaticcholesterolforfecalexcretion
AT marthadwilson acutesteroloacyltransferase2soat2knockdownrapidlymobilizeshepaticcholesterolforfecalexcretion
AT richardglee acutesteroloacyltransferase2soat2knockdownrapidlymobilizeshepaticcholesterolforfecalexcretion
AT rosannemcrooke acutesteroloacyltransferase2soat2knockdownrapidlymobilizeshepaticcholesterolforfecalexcretion
AT markjgraham acutesteroloacyltransferase2soat2knockdownrapidlymobilizeshepaticcholesterolforfecalexcretion
AT lawrencelrudel acutesteroloacyltransferase2soat2knockdownrapidlymobilizeshepaticcholesterolforfecalexcretion
AT jmarkbrown acutesteroloacyltransferase2soat2knockdownrapidlymobilizeshepaticcholesterolforfecalexcretion
AT ryanetemel acutesteroloacyltransferase2soat2knockdownrapidlymobilizeshepaticcholesterolforfecalexcretion